Results

Total Results: 634 records

Showing results for "rapid response".

  1. effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - may seem to be a natural choice when there is a dramatic s hift from one treatment to another (e.g., rapid … Evaluation of response time data involving transient states: an illustration using heart-transplant data
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … hydralazine/isosorbide dinitrate (H-ISDN) combination* VARIABLE GROUP Variable Categorical response
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
    January 01, 2013 - Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - It is a collaborative network of research centers that support the rapid development of new scientific … plan for depression should be documented If a patient with cancer is treated for depression, then response
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
    July 01, 2012 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - Other factors that may be considered in assessing strength of evidence include dose-response relationship
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … from draft CER for procalcitonin as a diagnostic indicator for infection and as an indicator of response … The response rate was 100 percent (n=9); 8 (of 10) research needs received votes. … The response rate was 100 percent (n=9); all questions received votes. … Host cytokine response affects PCT levels, so PCT cut-offs may differ in these populations.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
    December 11, 2012 - Ticagrelor is a reversible P2Y12 receptor antagonist that, when compared with clopidogrel, provides a more rapid … Initial pharmacokinetic/pharmacodynamic studies have suggested a reduction in the antiplatelet response … Based on comments received in response to this posting, the following change was made to the KQs: … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence
  9. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - If C1INH is deficient, an acute inflammatory response occurs that leads to swelling, which is the … If C1INH is deficient, C1 proteases set off the complement pathway, causing an acute inflammatory response … Part of the inflammatory response is the release of uncontrolled levels of bradykinin (BK), a potent … The combination of rapid relief of symptoms and self-administration is expected to improve health outcomes … the retina using tests for refraction, color vision, visual field, visual acuity, and pupil-reflex response
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - subject matter experts referred to a publication outlining perceived shortcomings of the report and a response … The response from the epilepsy organizations highlighted that the report failed to recognize the different … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response … Assessment of the Need to Update Comparative Effectiveness Reviews: Report of an Initial Rapid Program … individual patient or subset of patients would have an over- or under-accentuated pharmacokinetic response
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
    May 01, 2012 - It is a collaborative network of research centers that support the rapid development of new scientific … early events, especially treatment discontinuations, because of problems with tolerability or poor response … Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
    August 18, 2011 - helping patients to better adhere to recommended treatment. 4-6 Over the past half century, rapid … and alternatives to the prescribed medication; and lack of access to a provider who will monitor the response … It also considers other optional domains that may be relevant for some scenarios, such as a dose-response
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-evidence_methods.pdf
    November 01, 2013 - considered for some bodies of evidence and increase confidence in the findings include increasing dose-response … required, domains are most relevant to bodies of evidence consisting of observational studies: dose-response … The second set of domains, which supplement the five required domains, has three components: dose-response … Score as one of two levels: • Present: Dose-response pattern observed • Undetected: No dose-response … pattern observed (dose-response relationship not present or could not be determined) Plausible

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: